KITD816VandJAK2V617Fmutations are seen recurrently in hypereosinophilia of unknown significance-Reference-Cited by-同舟云学术

KITD816VandJAK2V617Fmutations are seen recurrently in hypereosinophilia of unknown significance

Published:2015-08-14 Issue:9 Volume:90 Page:774-777
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Schwaab Juliana¹,Umbach Roland¹,Metzgeroth Georgia¹,Naumann Nicole¹,Jawhar Mohamad¹,Sotlar Karl²,Horny Hans-Peter²,Gaiser Timo³,Hofmann Wolf-Karsten¹,Schnittger Susanne⁴,Cross Nicholas C.P.⁵⁶,Fabarius Alice¹,Reiter Andreas¹

Affiliation:

1. Department of Hematology and Oncology; University Hospital Mannheim; Mannheim Germany

2. Department of Pathology; Ludwig Maximilians University; Munich Germany

3. Department of Pathology; University Hospital Mannheim; Mannheim Germany

4. MLL, Munich Leukemia Laboratory; Munich Germany

5. Wessex Regional Genetics Laboratory; University of Southampton, Salisbury District Hospital; Salisbury United Kingdom

6. Faculty of Medicine; University of Southampton; Southampton United Kingdom

Funder

Deutsche José Carreras Leukämie Stiftung e.V.′ (H11/03), Germany

Publisher

Wiley

Subject

Hematology

Reference28 articles.

1. ICON: Eosinophil disorders;Valent;World Allergy Organ J,2012

2. Pathogenesis and classification of eosinophil disorders: A review of recent developments in the field;Valent;Expert Rev Hematol,2012

3. FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia;Cools;Verh K Acad Geneeskd Belg,2005

4. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1;Walz;Leukemia,2005

5. Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene;Walz;Genes Chromosomes Cancer,2006

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals;Current Hematologic Malignancy Reports;2024-07-22

2. Differentialdiagnose der Eosinophilie aus hämatologischer Sicht;Aktuelle Rheumatologie;2024-05-16

3. Involvement of the JAK‐STAT pathway in the molecular landscape of tyrosine kinase fusion‐negative hypereosinophilic syndromes: A nationwide CEREO study;American Journal of Hematology;2024-04-02

4. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management;American Journal of Hematology;2024-03-29

5. KIT Mutations and Other Genetic Defects in Mastocytosis;Immunology and Allergy Clinics of North America;2023-11